Literature DB >> 21732036

Clinical utility of the neutrophil distribution pattern obtained using the CELL-DYN SAPPHIRE hematology analyzer for the diagnosis of myelodysplastic syndrome.

Tohru Inaba1, Yoichi Yuki2, Soichi Yuasa2, Naohisa Fujita2, Kazue Yoshitomi3, Toshinori Kamisako3, Kunio Torii4, Toshiharu Okada4, Yoshimasa Urasaki5, Takanori Ueda6, Kaoru Tohyama7.   

Abstract

We evaluated the diagnostic utility of peripheral blood neutrophil distribution patterns obtained using the CELL-DYN SAPPHIRE hematology analyzer in patients with myelodysplastic syndrome (MDS). Peripheral blood was obtained from 467 individuals including 32 patients with MDS, and the respective neutrophil distribution patterns were observed using two light scatters [7-degree complexity (7D) and 90-degree lobularity (90D)]. These scattering intensities are shown as median (median neutrophil distribution: MND) and coefficient of variation (neutrophil distribution width: NDW). Generally, MDS patients showed lower 7D MND, higher 7D NDW, lower 90D MND and higher 90D NDW than other comparable groups. Whereas 90D parameters were more diagnostically efficient than 7D ones in patients with MDS. The sensitivity and specificity of 90D MND for MDS patients became 78.1 and 78.9%, respectively (cut-off value = 14,514). 90D NDW was most diagnostically effective with 87.5% sensitivity and 91.0% specificity (cut-off value = 21.2%). Both 90D parameters showed no evident correlation with the degree of either leukocytopenia or peripheral blood dysgranulopoiesis. In conclusion, neutrophil distribution parameters, especially 90D NDW, appear to provide convenient and objective markers for the screening of patients with MDS in routine laboratory hematology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732036     DOI: 10.1007/s12185-011-0892-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome.

Authors:  Elisabeth Haschke-Becher; Michael Vockenhuber; Paul Niedetzky; Uwe Totzke; Christian Gabriel
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

2.  Performance evaluation of the latest fully automated hematology analyzers in a large, commercial laboratory setting: a 4-way, side-by-side study.

Authors:  G Bourner; J Dhaliwal; J Sumner
Journal:  Lab Hematol       Date:  2005

3.  Aging stability of complete blood count and white blood cell differential parameters analyzed by Abbott CELL-DYN Sapphire hematology analyzer.

Authors:  P Hedberg; T Lehto
Journal:  Int J Lab Hematol       Date:  2008-01-07       Impact factor: 2.877

4.  Comparison of four hematology analyzers, CELL-DYN Sapphire, ADVIA 120, Coulter LH 750, and Sysmex XE-2100, in terms of clinical usefulness.

Authors:  S H Kang; H K Kim; C K Ham; D S Lee; H I Cho
Journal:  Int J Lab Hematol       Date:  2008-12       Impact factor: 2.877

5.  Four-parameter white blood cell differential counting based on light scattering measurements.

Authors:  L W Terstappen; B G de Grooth; K Visscher; F A van Kouterik; J Greve
Journal:  Cytometry       Date:  1988-01

6.  Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.

Authors:  Sindhu Cherian; Jonni Moore; Andrew Bantly; Jo-Anne Vergilio; Peter Klein; Selina Luger; Adam Bagg
Journal:  Cytometry B Clin Cytom       Date:  2005-03       Impact factor: 3.058

7.  Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.

Authors:  M Stetler-Stevenson; D C Arthur; N Jabbour; X Y Xie; J Molldrem; A J Barrett; D Venzon; M E Rick
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

8.  Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.

Authors:  Sindhu Cherian; Jonni Moore; Andrew Bantly; Jo-Anne Vergilio; Peter Klein; Selina Luger; Adam Bagg
Journal:  Am J Hematol       Date:  2005-07       Impact factor: 10.047

Review 9.  Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.

Authors:  Harold J Olney; Michelle M Le Beau
Journal:  Leuk Res       Date:  2006-12-11       Impact factor: 3.156

Review 10.  Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.

Authors:  P Valent; H-P Horny
Journal:  Eur J Clin Invest       Date:  2009-05-06       Impact factor: 4.686

View more
  2 in total

1.  Mean platelet component and mean platelet volume as useful screening markers for myelodysplastic syndrome.

Authors:  Ryota Masutani; Toshiyuki Ikemoto; Ayako Maki; Hiroko Tanada; Yoshinori Iwatani; Mikio Watanabe; Takayuki Takubo; Yoshikatsu Okada
Journal:  Health Sci Rep       Date:  2018-05-02

2.  Unique characteristics of leukocyte volume, conductivity and scatter in chronic myeloid leukemia.

Authors:  Balan Louis Gaspar; Prashant Sharma; Neelam Varma; Dmitry Sukhachev; Ishwar Bihana; Shano Naseem; Pankaj Malhotra; Subhash Varma
Journal:  Biomed J       Date:  2019-05-06       Impact factor: 4.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.